A group of researchers from Georgia university have developed a vaccine that attacks tumours in mice and could begin phase I clinical trials to test the safety of the vaccine by late 2013.

Read the full story (News24)

William Ludwig, a 65 years old man who suffered from leukemia was the first to sign up for a  bold experiment at the University of Pennsylvania. T-cells were removed,  re engineered and dripped back to his veins. At the beginning William got so sick the doctors weren’t sure he can make it, but after few weeks the fevers were gone. And so was the leukemia.

Read the full story (NY times)

The medical team  at the University of Alberta Hospital offered a brain cancer patient at the age of 30 to use  DCA, a drug  used to treat rare metabolic disorders, which also showed the ability to shrink tumors in rats. After 15 months the tumor was gone, 3 other patient who took this drug had their tumors shrink significantly or stop growing.

Read the full story (theglobeandmail)

A French study shows some leukemia patients may be cured by taking cancer pills (Glivec), out of 69 patients who took the pills, 38%  were clear for up to two years.

Read the full story (reuters)

More than 100 celebrities,  including Kyra Sedgwick, Jay Leno and Ryan Seacrest,  will join together tonight for the “Stand Up To Cancer” telethon. This fundraising event will be aired by ABC, CBS, Fox, NBC and some cable channels commercial-free at the same time and all money raised will help funding an  innovative cancer research.

Read the full story (washingtonpost)

New research in Tel-Aviv university has found medical solution for cancer disease which will block blood supply to the tumor preventing it from spreading. This new treatment will allow living with cancer as chronic disease without the need to eliminate it within the body.

Read the full story (ScienceDaily)

Scientists from Monash University discovered new effective way of treating prostate cancer – the second most common cancer for men in the world.  The new treatment deals with resistent cells which cannot be cured using existing treatments by activating the beta estrogen receptor in the prostate.

Read the full story (sciencedaily)

New research in the U.S. show steady decrease in cancer death in the past three decades. The researchers said that this is a result of lot of improvements in cancer screening and better treatments. The decrease have shown in all age groups.

Read the full story (Reuters)

New cancer treatment shows great hope on its first clinical trial in London. A drug name olaparib was given to 60  patients all of them with advanced breast cancer, ovarian cancer and prostate cancer and all of them had mutations in the BRCA1 and BRCA2 genes associated with inherited forms of these cancers. The treatment decreases tumors’ size and did not damage healthy cells.

Read the full story (The Financial Times)

A large scale clinical trial performed at the institute for research in immunology and cancer located in Montreol, Canada, has acheive improved results at treating Cancer patients with Ribavirin – a common anti-viral drug. The new treatment can be useful in 30% of Cancer diseases include the most common ones.

Read the full story (ScienceDaily)